Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...

Comedian Amy Schumer, 44, has recently come clean about her struggle with Cushing’s syndrome, leading to a dramatic weight loss. Schumer's transformation has sparked conversation online, to which she ...

The “Trainwreck” star, 44, was first diagnosed with the disease in February 2024, after people noticed her face was unusually puffy. “I didn’t lose 30 lbs., I lost 50,” Schumer wrote in her newest ...

The comedian revealed the motive behind her recent transformation in an Instagram Reel on Monday, explaining that she lost 50 pounds in order to “survive” Cushing syndrome. The actress was diagnosed ...

If you have high blood sugar from Cushing’s syndrome, you know how challenging it can be to control. Surgery can sometimes cure the condition, but it is not always successful or possible for everyone.

Insilico Medicine Ltd. has described glucocorticoid receptor (GR) antagonists reported to be useful for the treatment of Cushing’s syndrome, Addison’s disease, osteoporosis, rheumatoid arthritis, ...

Compared with a matched population-based control group, patients with Cushing syndrome continued to exhibit elevated systolic and diastolic blood pressures along with reduced kidney function at least ...

SAN FRANCISCO -- The investigational selective glucocorticoid receptor modulator relacorilant led to improvements in blood pressure, fasting glucose, and weight for patients with adrenal ...

Great star corals in the grip of disease have been saved with probiotics — beneficial bacteria that attack or displace invading pathogens or possibly trigger immune responses to them. What’s causing ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...